Found 42 matching trials
BCG Vaccination Delivered Intradermally, Orally and by Combined Routes PHASE1 This study will assess the safety of a Bacillus Calmette-Guérin (BCG) vacci...
Show More Location
Saint Louis University - Center for Vaccine Development
Learn More & Join Trial
Sanaria PfSPZ Challenge With Pyrimethamine or Chloroquine Chemoprophylaxis Vaccination (PfSPZ-CVac Approach): A Randomized Double Blind Placebo Controlled Phase I/II Trial to Determine Safety and Protective Efficacy Against Natural Plasmodium Falcipa... PHASE1 Background:
Malaria remains a major global health problem. Malaria is spre...
Show More Location
Malaria Vaccine Center STTB/MRTC
Learn More & Join Trial
Efficacy and Safety of Anthrax Vaccine, GC1109 PHASE1 1. BACKGROUND The newly developed anthrax vaccine GC1109 has been proven sa...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
An Immunity Persistence Study of Live Attenuated Varicella Vaccine PHASE4 This an open phase Ⅳ clinical trial of live attenuated varicella vaccines m...
Show More Status
Enrolling By Invitation
Location
Xiangcheng County Center for Disease Control and Prevention
Learn More & Join Trial
STRIDE - STimulating Immune Response In aDvanced brEast Cancer PHASE3 EMD Serono has decided to permanently terminate the trial EMR 200038-010 (S...
Show More Learn More & Join Trial
A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women PHASE2 The purpose of this study is to evaluate the safety, ability of GSK Biologi...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine. PHASE3 To assess the long-term efficacy and safety of the subjects during the thir...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety, Reactogenicity, and Immunogenicity Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) PHASE2 This is randomized, placebo-controlled, observer-blinded, multi-center stud...
Show More Location
Korea University Ansan Hospital
Learn More & Join Trial
Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 3 to 17 Years(COVID-19) PHASE2 This study is a randomized, double-blinded, and placebo controlled phase Ⅱ ...
Show More Location
Hunan Provincial Center for Diseases Control and Prevention
Learn More & Join Trial
Simultaneous mRNA COVID-19 and IIV4 Vaccination Study PHASE4 This study is a prospective, randomized clinical trial. During this study, ...
Show More Location
John Hopkins University
Learn More & Join Trial